We are live on
!
Find out more
iBio
IBIO
IBIO
20 hedge funds and large institutions have $731K invested in iBio in 2018 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
500% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 1
300% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 1
43% more capital invested
Capital invested by funds: $510K → $731K (+$221K)
33% more funds holding
Funds holding: 15 → 20 (+5)
0% more ownership
Funds ownership: 0% → 0% (+0%)
Holders
20
Holders Change
+5
Holders Change %
+33.33%
% of All Funds
0.46%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
4
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$36.7K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$27.3K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$17.8K |
| 4 |
VF
Virtu Financial
New York
|
+$11.5K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$10.5K |
Top Sellers
| 1 |
ACP
Aveo Capital Partners
Englewood,
Colorado
|
-$13K |
| 2 |
BlackRock
New York
|
-$3.15K |
